<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1802244934
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MANNITOL 20 % I.V INFUSION 500 ML
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MANNITOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BC01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Mannitol 20% Injection U.S.P.</p><p>&sect; Treatment of initial acute renal insufficiency, (e.g. following trauma and shock)</p><p>&sect; Indicated for lowering cerebral pressure, congestive glucoma, edema of cardiac and nephrogenous origin, ascites</p><p>&sect; Indicated for forced diuresis in poisoning, commencement of osmotic diuresis in oliguria and Anuria.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Contraindications</strong></p></td></tr></tbody></table><p>Persisting Oliguria/ Anuria after test infusion, cardiac decompensation, conditions of dehydration, lung edema, endo cranial bleeding.</p><p><strong>note:</strong></p><p>The solutions are only indicated for osmotic therapy, pre-testing is necessary in oliguria and anuria (test infusion). Caution in cases of hypervolemia.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Precautions</strong></p></td></tr></tbody></table><p><strong>Do not use if leakage was found, solution is cloudy or contains particles. </strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Interaction with other Drugs</strong></p></td></tr></tbody></table><p>Mannitol solutions should not be mixed with other medicaments due to its concentration and dosage.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p><u>In case of oliguria or anuria</u></p><p>A test infusion with mannitol solution is necessary (e.g. Mannitol 20%) give 1 ml/Kg BW. within 5-10 min. (I.V.). if the urine volume is less than 50 ml/hr. Further infusion of 0.5 ml/Kg BW. Within 5-10 min. (I.V.) if the urine volume remains less than 50 ml/hr., treatment of mannitol 20% solution should be stopped immediately!</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong><em>Mannitol </em></strong><strong><em>20%</em></strong></p></td><td style="vertical-align:top"><p>Up to 0.3 g Mannitol/Kg BW/hr. i.e. 1.5-2 ml/ Kg BW/ hr.</p><p>Maximum dosage: 1.5 g Mannitol/Kg BW/ day i.e. 7.5-10 ml/Kg BW/ day</p></td></tr></tbody></table><p><strong>Administration</strong></p><p>In form of a short I.V. infusion. It is recommended to use an infusion system with filter.</p><p>Cava catheter is recommended.<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Too fast infusion or higher doses may cause acute volume loading of cardiocirculatory system particularly in cases of insufficient urine micturition.</p><p><strong>&nbsp;Note: </strong></p><p>Control of serum ionogram and water balance is indispensable.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&sect; Store at 20&deg; - 30&deg; C.</p><p>&sect; Protect from light.</p><p>&sect; If stored in cold conditions, the solution may crystallise, in such case and before using, Immerse in warm water till completely dissolved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>20%</p></td><td style="vertical-align:top"><p>Mannitol</p></td><td style="vertical-align:top"><p>20 g</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Water for Injection</p></td><td style="vertical-align:top"><p>Q.S.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Theor. Osmolarity</p></td><td style="vertical-align:top"><p>1098 mOsm/L</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>pH for all solutions</p></td><td style="vertical-align:top"><p>4.5 &ndash; 7.0</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Hypertonic Infusion Solution for Intravenous Administration.
Bottle size: 500 ml * 10 bottles.
Sterile, pyrogen free

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Kuwait Saudi Pharmaceutical Industries Company</p><p>Tel: +965 24745012/3/4</p><p>Fax: +965 24745361, P. O. Box: 5512, postal code: 13056 Safat, Kuwait</p><p>Website: <u>www.kspico.com</u></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>محلول مانیتول ۲۰٪ (ي س ف) وزن/ حجم</strong></p><p dir="RTL">&sect;&nbsp;&nbsp; علاج لحالات الفشل الكلوي الأولي الحاد (مثل حالات ما بعد الرضوض أو الصدم)،</p><p dir="RTL">&sect;&nbsp;&nbsp; يستعمل لخفض الضغط الدماغي، الجلوكوما الاحتقانية، الأورام أو احتباس السوائل بسبب خلل في القلب أو نفرونات الكلية، الاستسقاء البطني،</p><p dir="RTL">&sect;&nbsp;&nbsp; مدر للبول في حالات التسمم، لبدء الإدرار البولي الأسموزي في حالات عسر أو شح البول أو انقطاع البول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>نواهي الاستعمال</strong></p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">استمرار شح أو انقطاع البول بعد تجربة المحلول مع المريض، اضطراب معاوضة القلب، حالات الجفاف، حالات أودیما الرئة، حالات النزيف داخل الجمجمة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ملاحظة</strong>:</p><p dir="RTL">&nbsp;تعطى هذه المحاليل حصرًا كعلاج أسموزي، في حالات عسر أو انقطاع البول لابد من إجراء اختبار استجابة المريض لهذه المحاليل. لابد من أخذ الحذر و الحيطة عند استخدام هذه المحاليل في حالات زيادة حجم الدم في الدورة الدموية.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><u>في</u><u> </u><u>حالات</u><u> </u><u>شح</u><u> </u><u>أو</u><u> </u><u>انقطاع</u><u> </u><u>البول</u><u> </u></p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL">لابد أولًا من إجراء اختبار لمدى استجابة المريض لهذه المحاليل و قدرتها على التبويل. مثال: عند استخدام محلول مانیتول ۲۰٪ وزن/ حجم: يعطى المريض وريديًا ۱ مل/ كجم من وزن الجسم خلال ٥ - ۱۰ دقائق، فإذا نقص حجم البول الناتج عن ٥۰ مل/ ساعة فإنه يعاد اختباره بإعطائه وريديًا <sub>۲</sub>/<sup>١ </sup>مل/ كجم من وزن الجسم خلال ٥ - ۱۰ دقائق فإذا نقص حجم البول الناتج عن ٥۰ مل/ ساعة فلابد من وقف العلاج بمحاليل المانیتول فورًا.</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>۲۰٪</strong></p></td><td style="vertical-align:top"><p dir="RTL">حتى ۰,۳ جم مانیتول/ كجم من وزن الجسم/ ساعة، <u>أي</u> ١,٥ &ndash; &nbsp;۲ مل/ كجم من وزن الجسم/ یوم. الجرعة القصوى ھي: ۱,٥ جم مانیتول/ كجم من وزن الجسم/ ساعة <u>أي</u> ٧,٥ &nbsp;&ndash; ۱۰ مل/ كجم من وزن الجسم /یوم.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>طريقة</strong><strong> </strong><strong>التناول</strong></p><p dir="RTL">على شكل تسريب وريدي قصير. يوصى باستخدام نظام التسريب المصحوب بالفلتر. يوصى باستخدام قسطرة كافا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ذا أعطيت هذه المحاليل بجرعات سريعة أو بجرعة يومية كبيرة، فإن هذا قد يسبب حملًا و ضغطًا على نظام الدورة للجسم خاصة في حالات فشل أو نقص عملية التبويل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ملاحظة</strong><strong>:</strong></p><p dir="RTL">&nbsp;عند استعمال هذه المحاليل فلابد من مراقبة أیونوجرام الدم و التوازن المائي له.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&sect;&nbsp;&nbsp; يحفظ في درجة حرارة من ۲۰ &ndash; ۳۰ درجة مئوية.</p><p dir="RTL">&sect;&nbsp;&nbsp; يحفظ بعيدًا عن الضوء المباشر.</p><p dir="RTL">&sect;&nbsp;&nbsp; إذا خزن في مكان بارد فإن المحلول قد يتبلور لذا يجب تدفئته حتى تذوب هذه البلورات كليًا قبل الاستعمال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><u>يحتوي كل ١۰۰ مل من المحلول على</u><u>:</u></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">۲۰٪</p></td><td style="vertical-align:top"><p dir="RTL">مانيتول</p></td><td style="vertical-align:top"><p dir="RTL">۲۰ جم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">ماء للحقن</p></td><td style="vertical-align:top"><p dir="RTL">بقية المحلول</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">الضغط الأسموزي الافتراضي</p></td><td style="vertical-align:top"><p dir="RTL">١۰٩٨ ملي أوزم/ لتر</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">الأس الهيدروجيني (معدل الحموضة) لهذه المحاليل</p></td><td style="vertical-align:top"><p dir="RTL">٤,٥ &ndash; ٧,۰</p></td></tr></tbody></table><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>محاليل للحقن الوريدي عالية الضغط الاسموزي</p><p dir="RTL">عبوة حجم: ٥۰۰ مل X ١۰ عبوات</p><p dir="RTL">&nbsp;</p><p dir="RTL">معقم و خالي من الحميات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>الشركة المصنعة والمفوضة بالتسويق</u></strong></p><p dir="RTL"><strong>الشركة الكويتية السعودية للصناعات الدوائيه</strong></p><p dir="RTL">ص ب: 5512 ،الرمز البريدي: 13056 الصفاة، الكويت</p><p dir="RTL">هاتف: 96524745013-96524745014+</p><p dir="RTL">فاكس: 96524745361+</p><p dir="RTL">الموقع الالكتروني: www.kspico.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mannitol 20% Injection U.S.P.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 100 ml contains:
Mannitol 	20 g
Water for Injection 	Q.S.
Theor. Osmolarity	1098 mOsm/L
pH	4.5 - 7.0
(For full list of excipients, see section 6.1).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mannitol 20% Injection U.S.P.
Hypertonic Infusion Solution for Intravenous Administration

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Mannitol 20% is indicated for use as an osmotic diuretic in the following situations:</p><p>&bull; Promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible oliguric renal failure becomes established.</p><p>&bull; Reduction of intracranial pressure and cerebral oedema, when the blood-barrier is intact.</p><p>&bull; Reduction of elevated intraocular pressure when it cannot be lowered by other means.</p><p>&bull; Promotion of elimination of renally excreted toxic substances in poisoning.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology:</u></p><p>The choice of the specific mannitol concentration, dosage and rate of administration depends on the age, weight and clinical condition of the patient and concomitant therapy.</p><p><u>Adults and adolescents:</u></p><p>Acute renal failure</p><p>The general dose range for adults is 50 to 200 g mannitol (330 to 1320 ml) in a 24-hour period, with a dosage limit of 50 g mannitol (330 ml) on any one occasion. In most instances adequate response will be achieved at a dosage of 50 to 100 g mannitol/day (330 to 660 ml). The rate of administration is usually adjusted to maintain a urine flow of at least 30-50 ml per hour.</p><p>Only in emergency situations, the maximum infusion rate can be as high as 200 mg/kg infused over 5 minutes (see also test dose). After 5 minutes, the infusion rate should be readjusted to maintain a urine flow of at least 30-50 ml per hour, with a maximum dose of 200 g/24h.</p><p><em>Use in patients with oliguria or renal impairment</em></p><p>Patients with marked oliguria or suspected inadequate renal function should first receive a test dose of approximately 200 mg mannitol/kg bw (body weight) (1.3 ml/kg) infused over a period of 3 to 5 minutes. The response to the test dose is considered adequate if at least 30-50 ml/hour of urine is excreted for 2-3 hours. If an adequate response is not attained, a further test dose may be given. If an adequate response to the second test dose is not attained, treatment with mannitol should be discontinued and the patient reassessed as established renal failure may be present.</p><p><em>Reduction of intracranial pressure, cerebral volume and intraocular pressure</em></p><p>The usual dose is 1.5 to 2 g/kg bw (10 to 13 ml/kg bw), infused over 30 to 60 minutes. When used preoperatively, the dose should be administered 1 to 1.5 hours before surgery to obtain the maximum effect.</p><p><em>Promotion of elimination of renally excreted toxic substances in poisoning</em></p><p>In forced diuresis the dose of mannitol should be adjusted to maintain urinary output of at least 100 ml/hour. Positive fluid balance of 1-2 litres should be aimed for. An initial loading dose of approximately 25 g (165 ml) may be given.</p><p><u>Paediatric population:</u></p><p>In renal insufficiency, the test dose should be 200 mg mannitol/kg bw (1.3 ml/kg bw) over 3-5 minutes. The treatment dose ranges from 0.5 to 1.5 g/kg bw (3 ml to 10 ml/kg bw). This dose may be repeated once or twice, after an interval of 4 to 8 hours, if necessary.</p><p>For increased intracranial and intraocular pressure, the dose may be given over 30 to 60 minutes as for adults.</p><p><u>Elderly population:</u></p><p>As for adults, the dosage depends on the weight, clinical and biological condition of the patient and concomitant therapy. The general dose range is the same as for adults 50 to 200 g mannitol in a 24 hour period (330 to 1320 ml in a day ), with a dosage limit of 50 g mannitol (330 ml) on any one occasion. Since incipient renal insufficiency may be present, caution should be used when reviewing patient&#39;s status prior to dose selection.</p><p><u>Method of administration:</u></p><p>The solution is for intravenous administration through a sterile and non-pyrogenic equipment.</p><p>The osmolarity of the solution should be considered. Hyperosmolar mannitol solutions may cause vein damage.</p><p>This hypertonic solution should be administered via a large peripheral or, preferably, a central vein. Rapid infusion in peripheral veins may be harmful.</p><p>Use an administration set which includes a final in-line filter, because of the potential for mannitol crystals to form, and use an aseptic technique. The equipment should be primed with the solution in order to prevent air entering the system.</p><p>Do not remove the unit from the overwrap until ready for use. The inner bag maintains the sterility of the product.</p><p>Use only if the solution is clear without visible particles or discoloration and the seal is intact. Confirm the integrity of the bag. Use only if the container is undamaged. Administer immediately following insertion of the infusion set.</p><p>Mannitol solutions may crystallize when exposed to low temperatures. At higher concentrations, the solutions have a greater tendency to crystallize. Inspect for crystals prior to administration. If crystals are visible, re-dissolve by warming the solution up to 37&deg;C, followed by gentle agitation. Solutions should not be heated in water or in a microwave oven due to the potential for product contamination or damage. Only dry heat (for example, a warming cabinet) should be used. Allow the solution to cool to room or body temperature before re-inspection for crystals and use. Please see also sections 4.4 and 6.6.</p><p>For information on incompatibilities and preparation of the product and additives, please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Pre-existing plasma hyperosmolarity
• Severe dehydration
• Established anuria
• Severe heart failure
• Severe pulmonary congestion or pulmonary oedema.
• Active intracranial bleeding, except during craniotomy
• Disturbance of the blood-brain barrier
• Hypersensitivity to mannitol
• Failure to respond to test dosing (see section 4.2)
• Progressive renal damage or dysfunction after institution of mannitol therapy, including increasing oliguria and azotemia

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Hypersensitivity</p><p>Anaphylactic/anaphylactoid reactions, including anaphylaxis, as well as other hypersensitivity/infusion reactions have been reported with mannitol. Fatal outcome has been reported (see section 4.8).</p><p>The infusion must be stopped immediately if any signs or symptoms of a suspected hypersensitivity reaction develops. Appropriate therapeutic countermeasures must be instituted as clinically indicated.</p><p>Mannitol occurs in nature (e.g., in some fruits and vegetables) and is widely used as an excipient in drugs and cosmetics. Therefore, patients may be sensitized without having received intravenous treatment with mannitol.</p><p>&bull; CNS toxicity</p><p>CNS toxicity manifested by, e.g. confusion, lethargy, coma has been reported in patients treated with mannitol, in particular in the presence of impaired renal function. Fatal outcomes have been reported.</p><p>CNS toxicity may result from:</p><p>- High serum mannitol concentrations</p><p>- Serum hyperosmolarity resulting in intracellular dehydration within the CNS</p><p>- Hyponatraemia or other disturbances of electrolyte and acid/base balance secondary to mannitol administration.</p><p>At high concentrations, mannitol may cross the blood brain barrier and interfere with the ability of the brain to maintain the pH of the cerebrospinal fluid especially in the presence of acidosis.</p><p>In patients with preexisting compromised blood brain barrier, the risk of increasing cerebral oedema (general or focal) associated with repeated or continued use of mannitol must be individually weighed against the expected benefits.</p><p>A rebound increase of intracranial pressure may occur several hours after the use of mannitol. Patients with compromised blood brain barrier are at increased risk.</p><p>&bull; Risk of renal complications</p><p>Reversible, acute oligoanuric renal failure, has occurred in patients with normal pretreatment renal function who received large intravenous doses of mannitol.</p><p>Although the osmotic nephrosis associated with mannitol administration is, in principle reversible, osmotic nephrosis in general is known to potentially proceed to chronic or even end-stage renal failure.</p><p>Patients with pre-existing renal disease, or those receiving potentially nephrotoxic medicinal products, are at increased risk of renal failure following administration of mannitol. Serum osmolar gap and renal function should be closely monitored and appropriate action initiated, should signs of worsening renal function or haematuria appear.</p><p>Mannitol should be administered with caution to patients with severely impaired renal function. A test dose should be employed and therapy with mannitol continued only if an adequate urine flow is achieved (see section 4.2).</p><p>If the urine output declines or haematuria is observed during mannitol infusion, the patient&#39;s clinical status should be closely reviewed for developing renal impairment, and the mannitol infusion suspended, if necessary.</p><p>&bull; Risk of hypervolaemia</p><p>The cardiovascular status of the patient should be carefully evaluated before rapidly administering Mannitol 20% w/v.</p><p>High doses and/or high rates of infusion, as well as accumulation of mannitol (due to insufficient renal excretion of mannitol), may result in hypervolaemia, overexpansion of the extracellular fluid, which may lead to or exacerbate existing congestive heart failure.</p><p>Accumulation of mannitol may result if urine output continues to decline during administration and this may worsen existing or latent congestive heart failure.</p><p>If the patient&#39;s cardiac or pulmonary function deteriorates, treatment should be discontinued.</p><p>&bull; Risk of water and electrolyte imbalances, hyperosmolarity</p><p>Mannitol-induced osmotic diuresis may cause or worsen dehydration/hypovolaemia and hemoconcentration. Administration of mannitol may also cause hyperosmolarity.</p><p>Should patient serum osmolarity increase during treatment, the effects of mannitol on diuresis and reduction of intracranial and intraocular pressure may be impaired.</p><p>In addition, depending on dosage and duration of administration, electrolyte and acid/base imbalances may result from transcellular shifts of water and electrolytes, osmotic diuresis and/or other mechanisms. Such imbalances may be severe and potentially fatal.</p><p>Imbalances that may result from mannitol treatment include:</p><p>&bull; Hypernatraemia, dehydration and hemoconcentration (resulting from excessive water loss)</p><p>&bull; Hyponatraemia (Shift of sodium-free intracellular fluid into the extra cellular compartment following mannitol infusion may lower serum sodium concentration and aggravate pre-existing hyponatraemia. Loss of sodium and potassium in the urine increases.)</p><p>Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral oedema, and death. Acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.</p><p>The risk for developing hyponatraemia is increased, for example,</p><p>&ndash; in children</p><p>&ndash; in elderly patients</p><p>&ndash; in women</p><p>&ndash; postoperatively</p><p>&ndash; in persons with psychogenic polydipsia.</p><p>The risk for developing encephalopathy as a complication of hyponatraemia is increased, for example,</p><p>&ndash; in paediatric patients (&le;16 years of age)</p><p>&ndash; in women (in particular, premenopausal women)</p><p>&ndash; in patients with hypoxaemia</p><p>&ndash; in patients with underlying central nervous system disease.</p><p>&bull; Hypokalaemia</p><p>&bull; Hyperkalaemia</p><p>&bull; Other electrolytes imbalances</p><p>&bull; Metabolic acidosis</p><p>&bull; Metabolic alkalosis</p><p>By sustaining diuresis, mannitol administration may obscure and intensify inadequate hydration or hypovolaemia.</p><p>&bull; Infusion reactions</p><p>Infusion site reactions have occurred with the use of mannitol. They include signs and symptoms of infusion site irritation and inflammation, as well as severe reactions (compartment syndrome) when associated with extravasation. See section 4.8.</p><p>Adding other medications or using an incorrect administration technique may cause febrile reactions due to possible introduction of pyrogens. In case of an adverse reaction, infusion must be stopped immediately. For information on incompatibilities and preparation of the product and additives, please see sections 6.2 and 6.6.</p><p>&bull; Volume and electrolyte replacement before use</p><p>In patients with shock and renal dysfunction, mannitol should not be administered until volume (fluid; blood) and electrolytes have been replaced.</p><p>&bull; Monitoring</p><p>The acid base balance, renal function and serum osmolarity must be monitored carefully when mannitol is used.</p><p>Patients receiving mannitol should be monitored for any deterioration in renal, cardiac or pulmonary function and treatment discontinued in the case of adverse events.</p><p>Urinary output, fluid balance, central venous pressure and electrolyte balance (in particular serum sodium and potassium levels) should be carefully monitored.</p><p>&bull; Incompatibility with blood</p><p>Mannitol should not be given concomitantly with blood because it may cause agglutination and crenation of blood cells.</p><p>&bull; Crystallization</p><p>When exposed to low temperatures, solutions of mannitol may crystallize. Inspect for crystals prior to administration. If crystals are visible, redissolve by warming the solution up to 37&deg;C, followed by gentle agitation. See section 4.2.</p><p>&bull; Laboratory test interferences</p><p>Mannitol can cause false low results in some tests systems for inorganic phosphorus blood concentrations.</p><p>Mannitol produces false positive results in tests for blood ethylene glycol concentrations in which mannitol is initially oxidized to an aldehyde.</p><p>&bull; Paediatric use</p><p>Safety and effectiveness in the paediatric population have not been established in clinical studies.</p><p>&bull; Geriatric use</p><p>In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy.</p><p>&bull; Risk of air embolism</p><p>Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed.</p><p>Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration.</p><p>Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effect Potentialisation</u></p><p>Concurrent use of other diuretics may potentiate the effects of mannitol and dose adjustments may be required.</p><p><u>Effect Inhibition</u></p><p>Mannitol promotes urine flow, which will mainly affect drugs that are renally reabsorbed to a large extent - thereby increasing their clearance and reducing their exposure<em>.</em></p><p>Mannitol increases urinary excretion of lithium and, therefore, concomitant use of mannitol may impair the response to lithium.</p><p><u>Nephrotoxicity of drugs due to fluid imbalance related to mannitol</u></p><p>Although an interaction in humans is unlikely, patients receiving concomitant cyclosporine and aminoglycoside should be closely monitored for signs of nephrotoxicity.</p><p><u>Neurotoxic agents</u></p><p>Concomitant use of neurotoxic agents (e.g. aminoglycoside) and mannitol may potentiate the toxicity of neurotoxic agents. (See also section 4.4).</p><p><u>Agents affected by electrolyte imbalances</u></p><p>The development of electrolyte imbalances (e.g., hyperkalaemia, hypokalaemia) associated with mannitol administration may alter the effects of agents that are sensitive to such imbalances (e.g., digoxin, agents that may cause QT prolongation, neuromuscular blocking agents).</p><p>Other potential interactions are with tubocurarine and depolarising neuromuscular blocking drugs (enhancement of their effects by mannitol), oral anticoagulants (mannitol may reduce their effects by increasing the concentration of clotting factors secondary to dehydration) and digoxin (if hypokalaemia follows mannitol treatment there is a risk of digoxin toxicity).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>There are no relevant published data from the use of mannitol in pregnant women.</p><p>There are no relevant published data from animal studies with respect to mannitol effect on pregnancy and/or embryo/foetal development and/or parturition and/or postnatal development.</p><p>Mannitol should not be used during pregnancy unless clearly needed.</p><p>There is no information on excretion of mannitol in breast milk.</p><p>Mannitol should not be used during lactation unless clearly needed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not stated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been reported in post-marketing experience. The frequency of the adverse drug reactions listed in this section cannot be estimated from the available data.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>MedDRA System Organ Class</strong></p></td><td><p><strong>Adverse reaction (MedDRA Preferred Term)</strong></p></td><td><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Allergic reaction</p><p>Anaphylactic reaction including anaphylactic shock*</p><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Fluid and electrolytes imbalance**</p><p>&bull; Dehydration</p><p>&bull; Oedema</p><p>Metabolic acidosis</p></td></tr><tr><td><p>Nervous system disorders</p></td><td><p>Headache</p><p>Dizziness</p><p>Rebound intracranial pressure increase</p><p>CNS toxicity manifested by</p><p>&bull; Convulsions</p><p>&bull; Coma</p><p>&bull; Confusion</p><p>&bull; Lethargy</p></td><td><p>Not known</p></td></tr><tr><td><p>Eye disorders</p></td><td><p>Blurred vision</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td><p>Cardiac arrhythmia</p><p>Congestive heart failure</p><p>Palpitations</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td><p>Hypotension</p><p>Hypertension</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td><p>Pulmonary oedema</p><p>Rhinitis</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td><p>Mouth dry</p><p>Thirst</p><p>Nausea</p><p>Vomiting</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td><p>Skin necrosis</p><p>Urticaria</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td><p>Cramps</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td><p>Excessive diuresis</p><p>Nephrosis osmotic</p><p>Urinary retention</p><p>Acute renal failure</p><p>Azotemia</p><p>Anuria</p><p>Haematuria</p><p>Oliguria</p><p>Polyuria</p></td><td><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td><p>Chills</p><p>Chest pain (angina-like chest pain)</p><p>Fever</p><p>Asthenia</p><p>Malaise</p><p>Infusion site reactions including</p><p>&bull; infusion thrombophlebitis</p><p>&bull; infusion site inflammation</p><p>&bull; infusion site pain</p><p>&bull; infusion site rash</p><p>&bull; infusion site erythema</p><p>&bull; infusion site pruritus.</p><p>Compartment syndrome (associated with extravasation and swelling at the injection site)</p></td><td><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p>*It can be manifested with skin, gastrointestinal, and severe circulatory (hypotension), and respiratory manifestations (e.g. dyspnea). Other hypersensitivity/infusion reactions, include hypertension, pyrexia, chills, sweating, cough, musculoskeletal stiffness and myalgia, urticaria/rash, pruritus, generalized pain, discomfort, nausea, vomiting, and headache.</p><p>** including hypervolaemia, peripheral oedema, dehydration, hyponatraemia, hypernatraemia, hyperkalaemia, hypokalaemia.</p><p><u>Other adverse reactions</u></p><p>Severe anaphylaxis with cardiac arrest, and fatal outcome.</p><p><u>Reporting of suspected adverse reactions</u></p><p><strong><u>The National Pharmacovigilance and Drug Safety Centre (NPC)</u></strong></p><p>&sect;&nbsp; <em>Fa</em><em>x</em><em>: </em>+966-11-205-7662</p><p>&sect;&nbsp; <em>Call NPC at:</em> +966-11-2038222, Ext.: 2317-2356-2353-2354-2334-2340.</p><p>&sect;&nbsp; <em>Reporting hotline: 19999</em></p><p>&sect;&nbsp; <em>E-mail:</em>npc.drug@sfda.gov.sa</p><p><em>Website: www.sfda.gov.sa/npc</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Signs and symptoms of overdose with mannitol may include acute renal failure, electrolyte imbalance, hypervoalaemia, CNS toxicity. Prolonged administration or rapid infusion of large volumes of hyperosmotic solutions may results in circulatory overload and acidosis. Headache, nausea and shivering without temperature change may represent initial signs/symptoms. Confusion, lethargy, convulsions, stupor and coma may follow.</p><p>In case of suspected overdose, treatment with mannitol should be stopped immediately.</p><p>Management is symptomatic and supportive, with monitoring of fluid and electrolyte balance.</p><p>Mannitol is dialyzable. Haemodialysis may be helpful.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: &ldquo;solutions producing osmotic diuresis.&rdquo;</p><p>ATC code: B 05BC01.</p><p>Mannitol, a carbohydrate, is confined to the extracellular compartment. It has an osmotic effect which causes fluid to pass from the intracellular to the extracellular compartment.</p><p>Mannitol is freely filterable at the kidney glomerulus and less than 10% is reabsorbed back from the kidney tubule. In the kidney tubules, mannitol exerts an osmotic effect which diminishes water reabsorption from the glomerular filtrate and produces diuresis. Mannitol thereby promotes urine flow in oliguria/anuria or in situations where the patient is at risk of onset of acute renal failure. Mannitol also increases electrolyte excretion, especially sodium, potassium and chloride. Excretion of renally excreted substances such as salicylates and barbiturates is also increased.</p><p>Mannitol does not penetrate the intact blood-brain barrier under usual circumstances. Confined to the plasma, mannitol exerts an osmotic pressure, causing fluid to leave the brain tissue, and brain volume and intracranial pressure to be reduced.</p><p>Mannitol does not penetrate the eye. Mannitol reduces the intraocular pressure due to its osmotic effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When administered intravenously, mannitol is eliminated largely unmetabolised through the glomeruli. Only 10% is reabsorbed back from the kidney tubule. The elimination half-life in adults is approximately 2 hours, longer where renal failure is present. 80% of an intravenous dose is excreted unchanged within 3 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>There are no preclinical data of relevance to the prescriber, which are additional to that already included in other sections of SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>The excipient in each 100 ml is:</em></strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p>Water for Injection</p></td><td><p>Q.S. to 100 ml</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Additives may be incompatible with Mannitol 20% w/v.</p><p>Incompatibility of the medicinal product to be added with the solution in the container must be assessed before addition.</p><p>Before adding a medicinal product, verify it is soluble and stable in water at the pH of the mannitol solution (4.5 to 7.0).</p><p>Mannitol 20% w/v should not be administered simultaneously with, before, or after administration of blood through the same infusion equipment, due to risk of pseudoagglutination. See section 4.4.</p><p>The instructions for use of the medicinal product to be added must be consulted.</p><p>As an example, cefepime, imipenem, cilastin and filgrastim are incompatible with mannitol solutions, but this list is not exhaustive. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p><p>The addition of potassium and sodium chloride to mannitol may lead to precipitation of mannitol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened:
5 years from the manufacturing date. The expiry date refers to the last day of the month.

After opening, with or without additives:
From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp; Keep in a safe place, out of the reach and sight of children.</p><p>&middot;&nbsp;&nbsp; Store at 20&deg; - 30&deg; C, Protect from light.</p><p>&middot;&nbsp;&nbsp; If stored in cold conditions, the solution may crystallise, in such case and before using, Immerse in warm water till completely dissolved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bottle size: 500 ml x 10 PE Bottles</p><p>Sterile, pyrogen free</p><p>White colored, round to oblong shaped granules, which are used for the production of containers for intravenous solutions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use administration sets with a final in-line filter because of the potential for mannitol crystals to form. For instructions on precautions to be taken before administration, in case of crystallization of the medicinal product, see section 4.2.</p><p>Additives may be introduced before infusion or during infusion through the re-sealable medication port.</p><p>Thorough and careful aseptic mixing of any additive is mandatory. Solutions containing additives should be used immediately and not stored.</p><p>Before adding a medicinal product, verify it is soluble in water at the pH of mannitol solution.</p><p>Chemical and Physical stability of any additive at the pH of Mannitol solution (4.5 to 7.0) in the bottle should be established prior to use.</p><p>Discard after single use.</p><p>Discard any unused portion.</p><p>Do not reconnect partially used bottle.</p><p><u>Opening</u></p><p>&bull; Check for minute leaks. If leaks are found, discard solution, as sterility may be impaired.</p><p>&bull; Check solution for limpidity and absence of foreign matter. If solution is not clear or contains foreign matter, discard the solution.</p><p><u>Preparation for administration</u></p><p>Use sterile material for preparation and administration.</p><p>&bull; Suspend container from eyelet support.</p><p>&bull; Remove plastic protector from outlet port at bottom of container</p><p>&bull; Use an aseptic method to set up the infusion.</p><p>&bull; Attach administration set. Refer to directions accompanying set for connection, priming of the set and administration of the solution.</p><p><u>Techniques for injection of additive medications</u></p><p>Warning: Additives may be incompatible. Check additive compatibility with both the solution and container prior to use.</p><p>To add medication before administration</p><p>&bull; Disinfect medication port.</p><p>&bull; Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</p><p>&bull; Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</p><p>Caution: Do not store bags containing added medications.</p><p><u>To add medication during administration</u></p><p>&bull; Close clamp on the set</p><p>&bull; Disinfect medication port.</p><p>&bull; Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</p><p>&bull; Remove container from IV pole and/or turn to an upright position.</p><p>&bull; Evacuate both ports by tapping gently while the container is in an upright position.</p><p>&bull; Mix solution and medication thoroughly.</p><p>&bull; Return container to in use position, re-open the clamp and continue administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Kuwait Saudi Pharmaceutical Industries Company
Tel: +965 24745012/3/4
Fax: +965 24745361, P. O. Box: 5512, postal code: 13056 Safat, Kuwait
Website: www.kspico.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>